Osteoporosis treatment

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/395 (2006.01) A61K 38/17 (2006.01) A61K 38/20 (2006.01) C07K 14/54 (2006.01) C07K 14/705 (2006.01) C07K 14/715 (2006.01) C07K 16/24 (2006.01) C07K 16/28 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2237915

There is disclosed a process of treating or alleviating the symptoms of pathological conditions involving increased bone resorption, which comprises inhibiting, in a mammalian patient suffering from such a condition, the formation in vivo of a tertiary complex of IL-11, its cell surface membrane receptor and the cell surface glycoprotein gp130. Examples of such substances are recombinant soluble IL-11 receptor mutants modified, as compared with native IL-11 receptor, at its gp130 binding site. The process of the invention not only inhibits bone resorption and hence bone loss, but also reverses the process to cause bone formation.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Osteoporosis treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Osteoporosis treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Osteoporosis treatment will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1930789

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.